BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
181 hedge funds and large institutions have $2.84B invested in Blueprint Medicines in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.39% more ownership
Funds ownership: 99.84% → 102.23% (+2.4%)
29% less capital invested
Capital invested by funds: $4B → $2.84B (-$1.16B)
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
Holders
181
Holding in Top 10
7
Calls
$37.1M
Puts
$21.4M
Top Buyers
| 1 | +$47.2M | |
| 2 | +$18.6M | |
| 3 | +$18.2M | |
| 4 |
Two Sigma Investments
New York
|
+$17.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$16.2M |
Top Sellers
| 1 | -$100M | |
| 2 | -$48.7M | |
| 3 | -$25.7M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$22.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$22M |